Abound Wealth Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.2K Hold
1,192
0.02% 181
2026
Q1
$62.3K Hold
1,192
0.01% 210
2025
Q4
$70.1K Buy
+1,192
New +$72.4K 0.02% 180
2025
Q1
Sell
-50
Closed -$3.6K 1327
2024
Q4
$3.6K Hold
50
﹤0.01% 596
2024
Q3
$4K Hold
50
﹤0.01% 589
2024
Q2
$3.58K Hold
50
﹤0.01% 556
2024
Q1
$3.52K Hold
50
﹤0.01% 597
2023
Q4
$3.86K Sell
50
-5
-9% -$329 ﹤0.01% 565
2023
Q3
$3.75K Hold
55
﹤0.01% 520
2023
Q2
$4.49K Buy
55
+5
+10% +$402 ﹤0.01% 512
2023
Q1
$3.71K Buy
50
+42
+525% +$3.24K ﹤0.01% 478
2022
Q4
$664 Hold
8
﹤0.01% 643
2022
Q3
$569 Buy
+8
New +$691 ﹤0.01% 653

Other funds holding TECH

Abound Wealth Management's TECH Position: Q2 2026 in Review

Abound Wealth Management held its Bio-Techne (TECH) position steady in Q2 2026 at 1,192 shares worth $84.2K. The position accounts for 0.02% of the portfolio, ranked #181.

Abound Wealth Management first reported a position in TECH in Q3 2022 and has held it in 13 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Abound Wealth Management held 1,192 shares of Bio-Techne worth $84.2K as of Q2 2026.
  • Abound Wealth Management left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up 0.02% of Abound Wealth Management's portfolio in Q2 2026, its #181 holding.
  • Abound Wealth Management first reported a position in Bio-Techne in Q3 2022 and has held it in 13 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.